Although positive correlations between FGF23 and total 25(OH)D and 24.25(OH)2D in MS patients were seen, no differences in plasma FGF23 concentrations between MS patients and healthy controls were observed. This evidence concerns the gene FGF23 and myeloid sarcoma.